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SUMMARY
The mechanism of neutrophil leucocytosis in cases of Japanese encephalitis is not known. We here
report that during Japanese encephalitis virus (JEV) infection in mice the splenic macrophages secrete
a chemotactic factor that attracts the neutrophils. The peak activity of macrophage derived factor
(MDF) was observed on day 7 following infection. The MDF acted in a dose-dependent manner.
This chemoattractant was purified by low pressure liquid chromatography and gave a single band of
10 kD on silver stained polyacrylamide gel. The MDF was found to be heat resistant and sensitive to
prolonged incubation with proteases.
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INTRODUCTION
The chemotactic peptides released from lipopolysaccharide-
stimulated human monocytes/macrophages (Wolpe et al., 1988;
Peveri et al., 1988), T lymphocytes (Gregory et al., 1988), B
lymphocytes (Altman, Chassy & Mackler, 1975) and fibroblasts
(Van Damme et al., 1989) have been shown to attract neutro-
phils, produce granulocytosis and induce local skin inflamma-
tory reaction. Some of the cytokines have been sequenced
(Davatelis et al., 1988; Matsushima et al., 1988). A single
peptide of 72 amino acids has been shown to be responsible for
neutrophil-stimulating activity (reviewed by Westwick, Li &
Camp, 1989). The chemotactic molecule has been recently
renamed as IL-8 (Larsen et al., 1989).
Leucopenia with lymphopenia is a frequent feature of most
of the viral infections (deGruchy, 1976), while infection with
Japanese encephalitis virus (JEV), a flavivirus (Shope, 1980) is
characterized by polymorphonuclear leucocytosis with variable
effect on different components of the peripheral blood leuco-
cytes (Chaturvedi et al., 1979). Our previous histopathological
studies of mice showed initial accumulation of macrophages
followed by neutrophils at the site of injury in the spleen
(Mathur et al., 1988). We have studied this phenomenon by
priming mice with JEV and assaying the individual cell popula-
tion for chemotactic activities. We present data demonstrating
the production of a previously unrecognized neutrophil chemo-
tactic cytokine secreted by the macrophages in spleen during
JEV infection.
Correspondence: Professor Asha Mathur, Department of Micro-
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MATERIALS AND METHODS
Antigen and animals
JEV, strain 78668A, was used as infected mouse brain suspen-
sion. The infectivity titre of five times passed brain pool
measured by intracerebral inoculation in infant mice was 104
50% lethal dose (LD5o) per 25 gil. JEV given intraperitoneally
produced no clinically evident disease, while intracerebral
inoculation produced uniform sickness and 100% mortality by
day 6 (Mathur, Arora & Chaturvedi, 1981). Inbred Swiss albino
mice obtained from this Department were used throughout the
study.
Preparation ofmacrophage derivedfactor (MDF)
The chemotactic factor was prepared from the spleen of JEV-
infected mice. Briefly, the mice were given 0-3 ml of 102 LD50 of
JEV intraperitoneally. The spleens were collected aseptically on
day 7 post-infection (p.i.) and teased out in chilled HBSS. The
cells (1 x 107/ml) were seeded in glass Petri dishes with MEM-
Hepes (25 mM) for I h at 37°C. The non-adherent cells were
removed and Petri dishes were thoroughly washed with phos-
phate-buffered saline (PBS). More than 90% of these cells were
macrophages as judged by morphology and phagocytosis of
latex particles (Mathur et al., 1988). The adherent cells were
cultured in saline for 24 h and the supernatant was tested for
chemotactic activity.
Cell culture
The glass adherent cells were separated from normal mouse
spleen in MEM-Hepes. The T and B lymphocyte-enriched
populations were obtained by successive filtration of non-
adherent cells through a nylon wool column by the modified
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technique ofJulius, Simpson & Herzenberg (1973) as previously
described (Mathur, Arora & Chaturvedi, 1983). The purity of
T and B lymphocytes was checked by treating the cells with anti-
Thy 1.2 antisera or anti-mouse IgG antisera (New England
Nuclear, Cambridge, MA) and complement. With this pro-
cedure pure populations ofT and B lymphocytes (95% and 94%
respectively) were obtained. The cells were washed three times
with MEM. Total spleen cells, macrophages, T and B lympho-
cytes were cultured (5 x 106 cells/ml) in MEM-Hepes with
antibiotics.
Purification ofmacrophage derivedfactor
The crude supernatant from splenic macrophages of JEV
primed mice was concentrated by freeze drying in Speed Vac
(Savant Instruments Inc., New York). The concentrated super-
natant was subjected to low pressure liquid-chromatography
(LPLC) using Sephacryl S-200 column (Pharmacia, Uppsala,
Sweden) in 0-1 M PBS, pH 7 4, at flow rate of 100 drops/min and
collected in 2 5 ml fractions. Absorbance was monitored at 280
nm as a parameter for protein concentration and the corres-
ponding peaks were recorded (2210 recorder, LKB Instruments,
Bromma, Sweden). The fractions were assayed for chemotactic
activity. The active fractions were pooled and concentrated and
applied again on Sephacryl S-200 column.
SDS-PAGE
The purity ofchemotactic fraction was tested by SDS-PAGE in
linear gradient (10-18%) polyacrylamide gels as described by
Laemmli (1970). Silver staining of proteins in the gel was carried
out according to the method of Merril et al. (1981). The
following molecular weight standards were run in parallel:
carbonic anhydrase (30 kD), trypsin inhibitor (21-5 kD),
lysozyme (14-3 kD), aprotinin (6-5 kD).
Assay of neutrophil chemotaxis
Neutrophils were obtained from mice 6 h after i.p. inoculation
of I ml of glycogen (0-10% in saline); more than 850X of the
recovered cells were neutrophils. These were further enriched by
gradient centrifugation (30 min, 400g) on Ficoll-Hypaque. The
cells in the pellet which consisted of 95O/ neutrophils were
washed three times with HBSS and suspended (1 x 108 cells/ml)
in HBSS. Neutrophil chemotaxis was assessed by a Boyden
chamber assay (Pohajdak et al., 1986). Briefly, the neutrophils
(1 5 x 106 in 200 ,ul) in HBSS were placed in the top compart-
ment and bottom chambers were filled with various chemo-
attractants or HBSS serving as negative control. N-formyl-
methionyl-leucyl-pheny-lalanine (FMLP) (Sigma Chemical
Co., St Louis, MO) at a concentration of 10-7 M was used as
positive control. The chambers were incubated for 1 h at 37 C in
a humidified 5% CO2 atmosphere before the filters were
removed, fixed in 70% isopropyl alcohol and stained with
haematoxylin. The number of neutrophils migrated into the
filter in high power fields (hpf, x 400) was counted. Each sample
was tested in triplicate with neutrophil migration counted in five
to seven fields and the mean migration + s.e. was calculated.
Protein assay
Protein content was measured by the technique of Lowry et al.
(1951).
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Fig. 1. Spleen cell neutrophil chemotactic activity at different periods of
JEV-primed mice (-), normal mice (A). FMLP (10-7) (0) was used as
positive control and MEM (0) as negative control. Each sample was
tested in triplicate with neutrophil migration counted in five to seven
high power field.
Protease treatment
Purified MDF was incubated at 37 C with and without trypsin
(Sigma) or chymotrypsin (Sigma) (100 jig/ml) for 4 h and 18 h
followed by addition of an excess of bovine serum albumin
(BSA) (2 mg/ml) before the chemotactic activity of MDF was
assayed.
RESULTS
Production of neutrophil chemotactic activity by spleen cells of
JE V-primed mice
The ability ofJEV-primed spleen cell supernatants to synthesize
chemotactic cytokine was studied. Figure I shows that the
maximum production of neutrophil chemotactic activity was
obtained on day 7 following inoculation of 0-3 ml of 10 LD50 of
JEV intraperitoneally (mean migration/hpf= 39 + 1 9). Normal
mouse spleen cell supernatant did not show detectable amounts
of chemotactic activity (mean migration/hpf=4+ 1 5).
Identification of splenic cell population producing chemotactic
activity'
In order to delineate the cell type responsible for chemotactic
activity in vitro, normal mouse splenic macrophages, T and B
lymphocytes (5 x 106 cells/ml) were cultured and stimulated with
101 LD50 of JEV. The supernatants collected at 24 h, 48 h and
72 h were assayed for chemotactic activity. The chemotactic
activity was produced by JEV-stimulated macrophages only,
while T and B lymphocyte supernatants failed to attract
neutrophils (Table 1). Control supernatants were found to be
inactive.
In the present study the splenic macrophage culture super-
natant of day 7 following JEV infection of mouse was used as
chemotactic cytokine.
n
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Table 1. Production of neutrophil chemotactic activity in ritro
Neutrophil migration/hpf (hours)
JEV-stimulated culture
supernatant 24 48 72
Macrophage 18±+16 30+3 2 22+0 8
T lymphocytes 3 + 0-5 4+0 7 2 +±05
B lymphocytes 5+0 7 6 + 0 3 2 + 0-5
The counts are presented after deducting the background values
obtained with MEM. Number of neutrophils migrated/hpf with 10-7 M
FMLP was 38 ± 2 4. Values are presented as mean + s.e.
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Fig. 3. Purification of macrophage-derived factor by low pressure liquid
chromatography ( ) and neutrophil chemotactic activity ( ).
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Fig. 2. Neutrophil chemotactic response at different dilutions of MDF.
Each dilution was tested in triplicate with neutrophil migration counted
in five to seven high power field.
Dose response ofneutrophil chemotactic activity
Figure 2 shows that the chemotactic activity ofMDF was dose-
dependent. Progressive decrease in chemotactic activity was
observed with increasing dilution of MDF.
Purification of macrophage-derived chemotactic activity
Crude supernatant of JEV-primed mouse splenic macrophage
culture having neutrophil chemotactic activity was concen-
trated and applied to the Sephacryl S-200 column. Figure 3
shows the elution profile of different proteins present in the
supernatant. Neutrophil chemotactic activity was recovered in
peak 4 corresponding to fractions 23-26 and fractions 27 and
28. The active fractions were pooled, concentrated and applied
on Sephacryl S-200 column again as a second purification step.
The chemotactic activity was separated from peak 4 and was
present in fractions 27 and 28 only. This was verified for purity
and molecular weight determination by SDS-PAGE using
100 pg of purified MDF and showed a single band of 10 kD
between lysozyme and aprotinin (Fig. 4).
Effect of JEV-antiserum treatment on MDF
The MDF was incubated with an equal volume of 1: 10 diluted
JEV-specific antiserum (supplied by the Director, National
Institute of Virology, Pune, India) at 37TC for h. Similarly
treated normal mouse macrophage culture supernatant and
MDF with diluent were used as controls. The chemotactic
activity of antisera-treated MDF was assayed and compared
with controls. The neutrophil chemotactic activity ofMDF was
not affected by JEV antiserum treatment (mean migration/hpf
33+ 19).
Characteri-zation (f MDF
Findings summarized in Table 2 show almost no loss in the
chemotactic activity ofMDF at 37 C, while heating to 100 C for
5 min resulted in a 340% reduction in activity. The MDF was
frozen at -70 C without loss of activity. The pH of MDF was
adjusted to 2 or 9 and incubated at 22 C for 3 h, followed by
readjustment ofpH to 7. Findings summarized in Table 2 show
0*05
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Fig. 4. SDS-PAGE of purified MDF. Molecular weight standards are
applied in lane 1. The position of MDF in the gel is indicated by an
arrow in lane 2.
Table 2. Physicochemical properties of MDF
Neutr(
Treatment
Trypsin (100 jig/ml)
4 h, 37 C
Control
18 h, 37 C
Control
Chymotrypsin (100 pg/ml)
4 h, 37 C
Control
18 h, 37-C
Control
Temperature
37 C, 3 h
560C, I h
100'C, 5 min
-70 C
Control (22 C)
pH 20
22-C, 3 h
Control
pH 90
22 C, 3 h
Control
ophil migration/
hpf (±s.e.)
31+34
30+4 6
1 +04
26_+41
36+ 25
35+50
10 + 09
27_1 11
28+39
28+28
19+ 15
30 + 20
29±0 5
33+44
32+3 6
34+22
35+3-0
Activity
(0N, of control)
100
3
100
3
96
96
66
100
100
97
Values are presented as mean of five duplicate experiments.
that the chemotactic activity of MDF was stable at acid and
alkaline pH.
The chemotactic activity of the purified MDF was assayed
after incubation with 100 jig/ml of trypsin or chymotrypsin for
4 h and 18 h. The results (Table 2) show no change in the
chemotactic activity ofMDF at 4 h while prolonged incubation
with proteases resulted in complete loss of activity, indicating
that MDF is a polypeptide.
DISCUSSION
Japanese encephalitis virus, a flavirirus (Shope, 1980) is the most
important cause of encephalitis, with high mortality world over
(Burke et al., 1985; Mathur et al., 1990). After haematogenous
spread of the JEV, an early influx of macrophages with
subsequent accumulation of neutrophils at the site of injury in
humans (Johnson et al., 1985) and in mice (Mathur et al., 1988),
polymorphonuclear leucocytosis (Chaturvedi et al., 1979) and
the presence of a large number of neutrophils in cerebrospinal
fluid (Johnson, Intralawan & Puapanwatton, 1986) have been
reported. Different cellular sources for soluble chemotactic
factor production are leucocytes, fibroblasts, epidermal and
endothelial cells (Westwick et al., 1989). We have not come
across any description of the release of neutrophil chemotactic
factor during JEV infection.
Our findings demonstrated the production of a highly potent
chemotactic factor by mouse splenic macrophages upon JEV
challenge that attracts neutrophils. We have termed this com-
pound macrophage derived factor (MDF). The induction of
chemotaxis was a dose-dependent phenomenon with a peak
chemotactic activity at day 7 p.i., indicating that its generation
depends on the influx of mononuclear phagocytes into the
affected tissue, as we have previously observed gradual increase
in number of macrophages in the spleen from day 3 after JEV
infection in mice followed by accumulation of neutrophils
(Mathur et al., 1988).
The MDF was found to be remarkably resistant to heat, acid
and alkaline pH. On the basis of protease sensitivity it appears
to be a polypeptide. MDF was purified by Sephacryl S-200
column chromatography and migrated as a single 10-kD protein
band on SDS-PAGE. A low molecular weight neutrophil
chemotactic protein has been reported after Con A or phyto-
haemagglutinin (PHA) stimulation of peripheral blood mono-
nuclear cells (Van Damme et al., 1988; Larsen et al., 1989).
Mononuclear leucocytes secrete biologically active chemo-
tactic cytokines in response to inflammatory stimuli (Westwick
et al., 1989). Neutrophil chemotactic peptides from lipopolysac-
charide-stimulated monocytes have been identified and
sequenced (Yoshimura et al., 1987; Peveri et al., 1988; Wolpe et
al., 1988). Over the past few years the chemotactic activity of
granulocytes has been attributed to IL-I (Dinarello & Mier,
1987). It has been suggested that IL-l is not directly responsible
for neutrophil chemotactic activity but can induce a chemotactic
protein (Strieter et al., 1988; Matsushima et al., 1988). Recently,
some groups have identified and sequenced the inflammatory
neutrophil chemotactic protein, IL-8. The activity is due to a
low mol. wt protein with molecular mass of about 10 kD
(Yoshimura et al., 1987). The mature chemotactic protein
occurs as a 6-7 kD protein (Van Damme et al., 1988) produced
by various types of cells (Larsen et al., 1989; Van Damme et al.,
1989) and is shown to be homologous with f3-thromboglobulin
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and platelet factor-4 (Van Damme et al., 1989). Identification of
MDF by NH2-terminal amino acid sequence analysis is in
progress, in order to make a detailed comparison with other
chemotactic cytokines.
JEV usually causes inapparent infection, but it can result in
encephalitis in a few cases. The exact mechanism involved in
initiation of brain infection is not known. We have recently
observed leakage of protein-bound Evan's blue and 5"Cr-
labelled erythrocytes into the extravascular space of brain tissue
in MDF-injected mice (data not included) as the evidence of an
increase in the capillary permeability resulting in breakdown of
the blood-brain barrier. Although the exact pathophysiological
relevance of MDF is yet to be established, the findings suggest
that MDF released during JEV infection elicits a rapid inflam-
matory response in vivo with neutrophil accumulation at the site
of injury.
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